Healthcare tech firm INDEGENE LTD reported strong numbers for the first quarter of FY26, with net profit rising 32.7% to ₹116.4 crore over ₹87.7 crore year-on-year.
Revenue for the period rose 12.5% to ₹760.8 crore from ₹676.5 crore in Q1FY25. EBITDA increased 20.7% to ₹156.4 crore.
Margins for the June quarter improved to 20.5%, up from 19.1% a year ago.
Manish Gupta, Chairman and CEO, Indegene, said, “We continued our growth momentum in Q1FY26, delivering 1.8% growth QoQ in USD. This reflects a strong start to the year and indicates good traction with our clients and from recent deal wins.”
Indegene CFO Suhas Prabhu said the company remains focused on mergers and acquisitions (M&A) opportunities.
This month, the company acquired Climacreative Spain SLU through its Irish subsidiary to expand its footprint in Europe.
“Both EBITDA margins and PAT margins were on stable lines, even as we continued investing on scaling engagements which allow us to move upstream in the marketing value chain; these have now started to generate revenue for us,” Prabhu added.
In 1998, Indegene was started as a pharma marketing and communications company, and has since evolved into a digital-first healthcare solutions company with offices in the US, UK, China, India, and Australia.
Shares of the company ended in the red on the BSE today (July 31) at ₹543 apiece, down ₹3.45 or 0.63%.
Also Read: Niva Bupa Health Q1 loss widens to ₹91 crore; gross premiums up 11% to ₹1,632 crore
First Published: Jul 31, 2025 8:43 PM IS
